Oklahoma 2022 Regular Session

Oklahoma Senate Bill SB12 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1	1
2	2
3		-	SB12 HFLR Page 1
4		-	BOLD FACE denotes Committee Amendments. 1
	3	+	ENGR. S. B. NO. 12 Page 1 1
5	4		2
6	5		3
7	6		4
8	7		5
9	8		6
10	9		7
11	10		8
12	11		9
13	12		10
14	13		11
15	14		12
16	15		13
17	16		14
18	17		15
19	18		16
20	19		17
21	20		18
22	21		19
23	22		20
24	23		21
25	24		22
26	25		23
27	26		24
28		-
29		-	HOUSE OF REPRESENTATIVES - FLOOR VERSION
30		-
31		-	STATE OF OKLAHOMA
32		-
33		-	1st Session of the 58th Legislature (2021)
34	27
35	28		ENGROSSED SENATE
36	29		BILL NO. 12 By: Standridge of the Senate
37	30
38	31		and
39	32
40	33		Kannady of the House
41	34
42	35
43	36
44	37
45	38		An Act relating to Uniform Controlled Dan gerous
46	39		Substances Act; amending 63 O.S. 2 011, Section 2-204,
47	40		as last amended by S ection 1, Chapter 207, O. S.L.
48	41		2019 (63 O.S. Supp. 2020, Section 2-204), which
49	42		relates to Schedule I; modifying inclusions; and
50	43		providing an effective dat e.
51	44
52	45
53	46
54	47
55	48		BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLA HOMA:
56	49		SECTION 1. AMENDATORY 63 O.S. 201 1, Section 2-204, as
57	50		last amended by Section 1, Chapter 207, O.S.L. 2019 (63 O.S. Supp.
58	51		2020, Section 2-204), is amended to read as follows:
59	52		Section 2-204. The controlled substances listed i n this section
60	53		are included in Schedule I and include any materia l, compound,
61	54		mixture or preparation that contains any quantity of the following
62	55		hallucinogenic substances, their salts, isomers and salts of
63	56		isomers, unless specifically excepted, when the ex istence of these
64	57		salts, isomers and salts of isomers is possible within the specific
65	58		chemical designation.
	59	+	A. Any of the following opiates , including their isomers,
	60	+	esters, ethers, salts , and salts of isomers, esters , and ethers,
	61	+	unless specifically excep ted, when the existence of t hese isomers,
66	62
67		-	SB12 HFLR Page 2
68		-	BOLD FACE denotes Committee Amendments. 1
	63	+	ENGR. S. B. NO. 12 Page 2 1
69	64		2
70	65		3
71	66		4
72	67		5
73	68		6
74	69		7
75	70		8
76	71		9
77	72		10
78	73		11
79	74		12
80	75		13
81	76		14
82	77		15
83	78		16
84	79		17
85	80		18
86	81		19
87	82		20
88	83		21
89	84		22
90	85		23
91	86		24
92	87
93		-	A. Any of the following opiates , including their isomers,
94		-	esters, ethers, salts , and salts of isomers, esters , and ethers,
95		-	unless specifically excepted, when the existence of these isomers,
96	88		esters, ethers, and salts is possible within the specific chemical
97	89		designation:
98	90		1. Acetylmethadol;
99	91		2. Allylprodine;
100	92		3. Alphacetylmethadol;
101	93		4. Alphameprodine;
102	94		5. Alphamethadol;
103	95		6. Benzethidine;
104	96		7. Betacetylmethadol;
105	97		8. Betameprodine;
106	98		9. Betamethadol;
107	99		10. Betaprodine;
108	100		11. Clonitazene;
109	101		12. Dextromoramide;
110	102		13. Dextrorphan (except its methyl ether);
111	103		14. Diampromide;
112	104		15. Diethylthiambutene;
113	105		16. Dimenoxadol;
114	106		17. Dimepheptanol;
115	107		18. Dimethylthiambutene;
116	108		19. Dioxaphetyl butyrate;
	109	+	20. Dipipanone;
	110	+	21. Ethylmethylthiambut ene;
	111	+	22. Etonitazene;
117	112
118		-	SB12 HFLR Page 3
119		-	BOLD FACE denotes Committee Amendments. 1
	113	+	ENGR. S. B. NO. 12 Page 3 1
120	114		2
121	115		3
122	116		4
123	117		5
124	118		6
125	119		7
126	120		8
127	121		9
128	122		10
129	123		11
130	124		12
131	125		13
132	126		14
133	127		15
134	128		16
135	129		17
136	130		18
137	131		19
138	132		20
139	133		21
140	134		22
141	135		23
142	136		24
143	137
144		-	20. Dipipanone;
145		-	21. Ethylmethylthiambutene;
146		-	22. Etonitazene;
147	138		23. Etoxeridine;
148	139		24. Furethidine;
149	140		25. Hydroxypethidine;
150	141		26. Ketobemidone;
151	142		27. Levomoramide;
152	143		28. Levophenacylmorphan;
153	144		29. Morpheridine;
154	145		30. Noracymethadol;
155	146		31. Norlevorphanol;
156	147		32. Normethadone;
157	148		33. Norpipanone;
158	149		34. Phenadoxone;
159	150		35. Phenampromide;
160	151		36. Phenomorphan;
161	152		37. Phenoperidine;
162	153		38. Piritramide;
163	154		39. Proheptazine;
164	155		40. Properidine;
165	156		41. Racemoramide; or
166	157		42. Trimeperidine.
	158	+	B. Any of the following opiu m derivatives, their salts,
	159	+	isomers, and salts of isomers, unless specifically excepted, when
	160	+	the existence of these salts, isomers , and salts of isomers is
	161	+	possible within the specific chemical designation:
167	162
168		-	SB12 HFLR Page 4
169		-	BOLD FACE denotes Committee Amendments. 1
	163	+	ENGR. S. B. NO. 12 Page 4 1
170	164		2
171	165		3
172	166		4
173	167		5
174	168		6
175	169		7
176	170		8
177	171		9
178	172		10
179	173		11
180	174		12
181	175		13
182	176		14
183	177		15
184	178		16
185	179		17
186	180		18
187	181		19
188	182		20
189	183		21
190	184		22
191	185		23
192	186		24
193	187
194		-	B. Any of the following opium derivatives, their salts,
195		-	isomers, and salts of isomers, unless specifically excepted, when
196		-	the existence of these salts, isomers , and salts of isomers is
197		-	possible within the specific chemical designation:
198	188		1. Acetorphine;
199	189		2. Acetyldihydrocodeine;
200	190		3. Benzylmorphine;
201	191		4. Codeine methylbromide;
202	192		5. Codeine-N-Oxide;
203	193		6. Cyprenorphine;
204	194		7. Desomorphine;
205	195		8. Dihydromorphine;
206	196		9. Etorphine;
207	197		10. Heroin;
208	198		11. Hydromorphinol;
209	199		12. Methyldesorphine;
210	200		13. Methylhydromorphine;
211	201		14. Morphine methylbromide;
212	202		15. Morphine methylsulfonate;
213	203		16. Morphine-N-Oxide;
214	204		17. Myrophine;
215	205		18. Nicocodeine;
216	206		19. Nicomorphine;
217	207		20. Normorphine;
	208	+	21. Phoclodine;
	209	+	22. Thebacon;
	210	+	23. N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-acetamide
	211	+	(Acetyl fentanyl);
218	212
219		-	SB12 HFLR Page 5
220		-	BOLD FACE denotes Committee Amendments. 1
	213	+	ENGR. S. B. NO. 12 Page 5 1
221	214		2
222	215		3
223	216		4
224	217		5
225	218		6
226	219		7
227	220		8
228	221		9
229	222		10
230	223		11
231	224		12
232	225		13
233	226		14
234	227		15
235	228		16
236	229		17
237	230		18
238	231		19
239	232		20
240	233		21
241	234		22
242	235		23
243	236		24
244	237
245		-	21. Phoclodine;
246		-	22. Thebacon;
247		-	23. N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-acetamide
248		-	(Acetyl fentanyl);
249	238		24. N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-butenamide
250	239		(Crotonyl fentanyl);
251	240		25. N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-2-
252	241		furancarboxamide (Furanyl fentanyl);
253	242		26. N-phenyl-1-(2-phenylethyl)-4-piperidinamine (4-ANPP);
254	243		27. N-(1-phenethylpiperidin-4-yl)-N-
255	244		phenylcyclopropanecarboxamide (Cyclopropyl fe ntanyl); or
256	245		28. N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-butanamide
257	246		(Butyrl fentanyl).
258	247		C. Any material, compound, mixtur e, or preparation which
259	248		contains any quantity of the following h allucinogenic substances,
260	249		their salts, isomers, and salts of isomers, unless specifically
261	250		excepted, when the existence of these salts, isomers, and salts of
262	251		isomers is possible within the spec ific chemical designation:
263	252		1. Methcathinone;
264	253		2. 3, 4-methylenedioxy amphetamine;
265	254		3. 3, 4-methylenedioxy methamphetamine;
266	255		4. 5-methoxy-3, 4-methylenedioxy amphetami ne;
267	256		5. 3, 4, 5-trimethoxy amphetamine;
268	257		6. Bufotenine;
	258	+	7. Diethyltryptamine;
	259	+	8. Dimethyltryptamine;
	260	+	9. 4-methyl-2, 5-dimethoxyamphetamine;
	261	+	10. Ibogaine;
269	262
270		-	SB12 HFLR Page 6
271		-	BOLD FACE denotes Committee Amendments. 1
	263	+	ENGR. S. B. NO. 12 Page 6 1
272	264		2
273	265		3
274	266		4
275	267		5
276	268		6
277	269		7
278	270		8
279	271		9
280	272		10
281	273		11
282	274		12
283	275		13
284	276		14
285	277		15
286	278		16
287	279		17
288	280		18
289	281		19
290	282		20
291	283		21
292	284		22
293	285		23
294	286		24
295	287
296		-	7. Diethyltryptamine;
297		-	8. Dimethyltryptamine;
298		-	9. 4-methyl-2, 5-dimethoxyamphetamine;
299		-	10. Ibogaine;
300	288		11. Lysergic acid diethylamide;
301	289		12. Marihuana;
302	290		13. Mescaline;
303	291		14. N-benzylpiperazine;
304	292		15. N-ethyl-3-piperidyl benzilate;
305	293		16. N-methyl-3-piperidyl benzilate;
306	294		17. Psilocybin;
307	295		18. Psilocyn;
308	296		19. 2, 5 dimethoxyamphetamine;
309	297		20. 4 Bromo-2, 5-dimethoxyamphetamine;
310	298		21. 4 methoxyamphetam ine;
311	299		22. Cyclohexamine;
312	300		23. Salvia Divinorum;
313	301		24. Salvinorin A;
314	302		25. Thiophene Analog of Phencyclidine. Also known as: 1 -(1-(2-
315	303		thienyl) cyclohexyl) piperidine; 2-Thienyl Analog of Phencyclidine;
316	304		TPCP, TCP;
317	305		26. Phencyclidine (PCP);
318	306		27. Pyrrolidine Ana log for Phencyclidine. Also known as 1 -(1-
319	307		Phenylcyclohexyl) - Pyrrolidine, PCPy, PHP;
	308	+	28. 1-(3-trifluoromethylphenyl) piperazine;
	309	+	29. Flunitrazepam;
	310	+	30. B-hydroxy-amphetamine;
	311	+	31. B-ketoamphetamine;
320	312
321		-	SB12 HFLR Page 7
322		-	BOLD FACE denotes Committee Amendments. 1
	313	+	ENGR. S. B. NO. 12 Page 7 1
323	314		2
324	315		3
325	316		4
326	317		5
327	318		6
328	319		7
329	320		8
330	321		9
331	322		10
332	323		11
333	324		12
334	325		13
335	326		14
336	327		15
337	328		16
338	329		17
339	330		18
340	331		19
341	332		20
342	333		21
343	334		22
344	335		23
345	336		24
346	337
347		-	28. 1-(3-trifluoromethylphenyl) piperazine;
348		-	29. Flunitrazepam;
349		-	30. B-hydroxy-amphetamine;
350		-	31. B-ketoamphetamine;
351	338		32. 2,5-dimethoxy-4-nitroamphetamine;
352	339		33. 2,5-dimethoxy-4-bromophenethylamine;
353	340		34. 2,5-dimethoxy-4-chlorophenethylamine;
354	341		35. 2,5-dimethoxy-4-iodoamphetamine;
355	342		36. 2,5-dimethoxy-4-iodophenethylamine;
356	343		37. 2,5-dimethoxy-4-methylphenethylamine;
357	344		38. 2,5-dimethoxy-4-ethylphenethylamine;
358	345		39. 2,5-dimethoxy-4-fluorophenethylamine;
359	346		40. 2,5-dimethoxy-4-nitrophenethylamine;
360	347		41. 2,5-dimethoxy-4-ethylthio-phenethylamine;
361	348		42. 2,5-dimethoxy-4-isopropylthio-phenethylamine;
362	349		43. 2,5-dimethoxy-4-propylthio-phenethylamine;
363	350		44. 2,5-dimethoxy-4-cyclopropylmethylthio -phenethylamine;
364	351		45. 2,5-dimethoxy-4-tert-butylthio-phenethylamine;
365	352		46. 2,5-dimethoxy-4-(2-fluoroethylthio)-phenethylamine;
366	353		47. 5-methoxy-N, N-dimethyltryptamine;
367	354		48. N-methyltryptamine;
368	355		49. A-ethyltryptamine;
369	356		50. A-methyltryptamine;
370	357		51. N, N-diethyltryptamine;
	358	+	52. N, N-diisopropyltryptamin e;
	359	+	53. N, N-dipropyltryptamine;
	360	+	54. 5-methoxy-a-methyltryptamine;
	361	+	55. 4-hydroxy-N, N-diethyltryptamine;
371	362
372		-	SB12 HFLR Page 8
373		-	BOLD FACE denotes Committee Amendments. 1
	363	+	ENGR. S. B. NO. 12 Page 8 1
374	364		2
375	365		3
376	366		4
377	367		5
378	368		6
379	369		7
380	370		8
381	371		9
382	372		10
383	373		11
384	374		12
385	375		13
386	376		14
387	377		15
388	378		16
389	379		17
390	380		18
391	381		19
392	382		20
393	383		21
394	384		22
395	385		23
396	386		24
397	387
398		-	52. N, N-diisopropyltryptamine;
399		-	53. N, N-dipropyltryptamine;
400		-	54. 5-methoxy-a-methyltryptamine;
401		-	55. 4-hydroxy-N, N-diethyltryptamine;
402	388		56. 4-hydroxy-N, N-diisopropyltryptamine;
403	389		57. 5-methoxy-N, N-diisopropyltryptamine;
404	390		58. 4-hydroxy-N-isopropyl-N-methyltryptamine;
405	391		59. 3,4-Methylenedioxymethcathinone (Methylone);
406	392		60. 3,4-Methylenedioxypyrovalerone (MDPV);
407	393		61. 4-Methylmethcathinone (Mephedrone);
408	394		62. 4-methoxymethcathinone;
409	395		63. 4-Fluoromethcathinone;
410	396		64. 3-Fluoromethcathinone;
411	397		65. 1-(8-bromobenzo 1,2-b;4,5-b’ difuran-4-yl)-2-aminopropane;
412	398		66. 2,5-Dimethoxy-4-chloroamphetamine;
413	399		67. 4-Methylethcathinone;
414	400		68. Pyrovalerone;
415	401		69. N,N-diallyl-5-methoxytryptamine;
416	402		70. 3,4-Methylenedioxy-N-ethylcathinone (Ethylone);
417	403		71. B-keto-N-Methylbenzodioxolylbutanamine (Butylone);
418	404		72. B-keto-Methylbenzodioxolylpentanamine (Pentylone);
419	405		73. Alpha-Pyrrolidinopentiophenone;
420	406		74. 4-Fluoroamphetamine;
421	407		75. Pentedrone;
	408	+	76. 4’-Methyl-a-pyrrolidinohexaphenone;
	409	+	77. 2,5-dimethoxy-4-(n)-propylphenethylamine;
	410	+	78. 2,5-dimethoxyphenethylamine;
	411	+	79. 1,4-Dibenzylpiperazine;
422	412
423		-	SB12 HFLR Page 9
424		-	BOLD FACE denotes Committee Amendments. 1
	413	+	ENGR. S. B. NO. 12 Page 9 1
425	414		2
426	415		3
427	416		4
428	417		5
429	418		6
430	419		7
431	420		8
432	421		9
433	422		10
434	423		11
435	424		12
436	425		13
437	426		14
438	427		15
439	428		16
440	429		17
441	430		18
442	431		19
443	432		20
444	433		21
445	434		22
446	435		23
447	436		24
448	437
449		-	76. 4’-Methyl-a-pyrrolidinohexaphenone;
450		-	77. 2,5-dimethoxy-4-(n)-propylphenethylamine;
451		-	78. 2,5-dimethoxyphenethylamine;
452		-	79. 1,4-Dibenzylpiperazine;
453	438		80. N,N-Dimethylamphetamine;
454	439		81. 4-Fluoromethamphetamine;
455	440		82. 4-Chloro-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine
456	441		(25C-NBOMe);
457	442		83. 4-Iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine
458	443		(25I-NBOMe);
459	444		84. 4-Bromo-2,5-dimethoxy-N-(2-methoxybenzy)phenethylamine
460	445		(25B-NBOMe);
461	446		85. 1-(4-Fluorophenyl)piperazine;
462	447		86. Methoxetamine;
463	448		87. 3,4-dichloro-N[2-dimethylamino)cyclohexyl] -N-
464	449		methylbenzamide;
465	450		88. N-ethyl hexadrone;
466	451		89. Isopropyl-U-47700;
467	452		90. Para-fluorobutyrl fentanyl;
468	453		91. Fluoro isobutryrl fentanyl;
469	454		92. 3-Hydroxy Phencyclidine (PCP); or
470	455		93. 3-methoxy Phencyclidine (PCP) ;
471	456		94. Flualprazolam; or
472	457		95. Flubromazolam.
	458	+	D. Unless specifically excepted or unless listed in a different
	459	+	schedule, any material, compound, mixture , or preparation which
	460	+	contains any quantity of the following substances having stimulant
	461	+	or depressant effect on the central nervous system:
473	462
474		-	SB12 HFLR Page 10
475		-	BOLD FACE denotes Committee Amendments. 1
	463	+	ENGR. S. B. NO. 12 Page 10 1
476	464		2
477	465		3
478	466		4
479	467		5
480	468		6
481	469		7
482	470		8
483	471		9
484	472		10
485	473		11
486	474		12
487	475		13
488	476		14
489	477		15
490	478		16
491	479		17
492	480		18
493	481		19
494	482		20
495	483		21
496	484		22
497	485		23
498	486		24
499	487
500		-	D. Unless specifically excepted or unless listed in a d ifferent
501		-	schedule, any material, compound, mixture , or preparation which
502		-	contains any quantity of the following substances having stimulant
503		-	or depressant effect on the central nervous system:
504	488		1. Fenethylline;
505	489		2. Mecloqualone;
506	490		3. N-ethylamphetamine;
507	491		4. Methaqualone;
508	492		5. Gamma-Hydroxybutyric Acid, also known a s GHB, gamma-
509	493		hydroxybutyrate, 4-hydroxybutyrate, 4-hydroxybutanoic acid, sodium
510	494		oxybate, and sodium oxybutyrate;
511	495		6. Gamma-Butyrolactone (GBL) as packaged, marketed,
512	496		manufactured or promoted for human consumption, wi th the exception
513	497		of legitimate food addi tive and manufacturing purposes;
514	498		7. Gamma Hydroxyvalerate (GHV) as packaged, marketed , or
515	499		manufactured for human consumption, with the exception of legitimate
516	500		food additive and manufacturing purposes;
517	501		8. Gamma Valerolactone (GVL) as packaged, marketed , or
518	502		manufactured for human consumption, with the exception of legitimate
519	503		food additive and manufacturing purposes;
520	504		9. 1,4 Butanediol (1,4 BD or BDO) as packaged, marketed,
521	505		manufactured, or promoted for human consumpti on with the exception
522	506		of legitimate manufacturing purposes; or
523	507		10. N-ethylpentylone.
	508	+	E. 1. The following industrial uses of Gamma -Butyrolactone,
	509	+	Gamma Hydroxyvalerate, Gamma Valerolactone , or 1,4 Butanediol are
	510	+	excluded from all schedules of controlled substances under this
	511	+	title:
524	512
525		-	SB12 HFLR Page 11
526		-	BOLD FACE denotes Committee Amendments. 1
	513	+	ENGR. S. B. NO. 12 Page 11 1
527	514		2
528	515		3
529	516		4
530	517		5
531	518		6
532	519		7
533	520		8
534	521		9
535	522		10
536	523		11
537	524		12
538	525		13
539	526		14
540	527		15
541	528		16
542	529		17
543	530		18
544	531		19
545	532		20
546	533		21
547	534		22
548	535		23
549	536		24
550	537
551		-	E. 1. The following industrial uses of Gamma -Butyrolactone,
552		-	Gamma Hydroxyvalerate, Gamma Valerolactone , or 1,4 Butanediol are
553		-	excluded from all schedul es of controlled substances under this
554		-	title:
555	538		a. pesticides,
556	539		b. photochemical etching,
557	540		c. electrolytes of small batteries or capacitors,
558	541		d. viscosity modifiers in polyurethane,
559	542		e. surface etching of metal coated plastics,
560	543		f. organic paint disbursements for water soluble in ks,
561	544		g. pH regulators in the dyeing of wo ol and polyamide
562	545		fibers,
563	546		h. foundry chemistry as a catalyst during curing,
564	547		i. curing agents in many coating systems based on
565	548		urethanes and amides,
566	549		j. additives and flavoring agen ts in food, confectionary ,
567	550		and beverage products,
568	551		k. synthetic fiber and cloth ing production,
569	552		l. tetrahydrofuran production,
570	553		m. gamma butyrolactone production,
571	554		n. polybutylene terephthalate resin production,
572	555		o. polyester raw materials for polyurethane elas tomers
573	556		and foams,
574	557		p. coating resin raw material, and
	558	+	q. as an intermediate in the manufacture of other
	559	+	chemicals and pharmaceuticals.
	560	+	2. At the request of any person, the Director may exempt any
	561	+	other product containing Gamma -Butyrolactone, Gamma Hydroxyv alerate,
575	562
576		-	SB12 HFLR Page 12
577		-	BOLD FACE denotes Committee Amendments. 1
	563	+	ENGR. S. B. NO. 12 Page 12 1
578	564		2
579	565		3
580	566		4
581	567		5
582	568		6
583	569		7
584	570		8
585	571		9
586	572		10
587	573		11
588	574		12
589	575		13
590	576		14
591	577		15
592	578		16
593	579		17
594	580		18
595	581		19
596	582		20
597	583		21
598	584		22
599	585		23
600	586		24
601	587
602		-	q. as an intermediate in the manufacture of other
603		-	chemicals and pharmaceuticals.
604		-	2. At the request of any person, the Director may exempt any
605		-	other product containing Gamma -Butyrolactone, Gamma Hydroxyvalerate,
606	588		Gamma Valerolactone, or 1,4 Butanediol from being included as a
607	589		Schedule I controlled substance if such product is labeled,
608	590		marketed, manufactured and distributed for legitimate industrial use
609	591		in a manner that reduces or eliminates the likelihood of abuse.
610	592		3. In making a determination regarding an industrial product,
611	593		the Director, after notice and hearing, shall consider the
612	594		following:
613	595		a. the history and current pattern of abuse,
614	596		b. the name and labeling of the product,
615	597		c. the intended manner of d istribution, advertising a nd
616	598		promotion of the product, and
617	599		d. other factors as may be relevant to and consistent
618	600		with the public health and safety.
619	601		4. The hearing shall be held in accordance with the procedures
620	602		of the Administrative Procedures Act.
621	603		F. Any material, compound, mixt ure, or preparation, whether
622	604		produced directly or in directly from a substance of vegetable origin
623	605		or independently by means of chemical synthesis, or by a combination
624	606		of extraction and chemical synthesis, that contains any quantit y of
625	607		the following substan ces, or that contains any of their salts,
	608	+	isomers, and salts of isomers when the existence of these salts,
	609	+	isomers, and salts of isomers is possible within the specific
	610	+	chemical designation:
	611	+	1. JWH-004;
626	612
627		-	SB12 HFLR Page 13
628		-	BOLD FACE denotes Committee Amendments. 1
	613	+	ENGR. S. B. NO. 12 Page 13 1
629	614		2
630	615		3
631	616		4
632	617		5
633	618		6
634	619		7
635	620		8
636	621		9
637	622		10
638	623		11
639	624		12
640	625		13
641	626		14
642	627		15
643	628		16
644	629		17
645	630		18
646	631		19
647	632		20
648	633		21
649	634		22
650	635		23
651	636		24
652	637
653		-	isomers, and salts of isomers when the existence of these salts,
654		-	isomers, and salts of isomers is possible within the specific
655		-	chemical designation:
656		-	1. JWH-004;
657	638		2. JWH-007;
658	639		3. JWH-009;
659	640		4. JWH-015;
660	641		5. JWH-016;
661	642		6. JWH-018;
662	643		7. JWH-019;
663	644		8. JWH-020;
664	645		9. JWH-030;
665	646		10. JWH-046;
666	647		11. JWH-047;
667	648		12. JWH-048;
668	649		13. JWH-049;
669	650		14. JWH-050;
670	651		15. JWH-070;
671	652		16. JWH-071;
672	653		17. JWH-072;
673	654		18. JWH-073;
674	655		19. JWH-076;
675	656		20. JWH-079;
676	657		21. JWH-080;
	658	+	22. JWH-081;
	659	+	23. JWH-082;
	660	+	24. JWH-094;
	661	+	25. JWH-096;
677	662
678		-	SB12 HFLR Page 14
679		-	BOLD FACE denotes Committee Amendments. 1
	663	+	ENGR. S. B. NO. 12 Page 14 1
680	664		2
681	665		3
682	666		4
683	667		5
684	668		6
685	669		7
686	670		8
687	671		9
688	672		10
689	673		11
690	674		12
691	675		13
692	676		14
693	677		15
694	678		16
695	679		17
696	680		18
697	681		19
698	682		20
699	683		21
700	684		22
701	685		23
702	686		24
703	687
704		-	22. JWH-081;
705		-	23. JWH-082;
706		-	24. JWH-094;
707		-	25. JWH-096;
708	688		26. JWH-098;
709	689		27. JWH-116;
710	690		28. JWH-120;
711	691		29. JWH-122;
712	692		30. JWH-145;
713	693		31. JWH-146;
714	694		32. JWH-147;
715	695		33. JWH-148;
716	696		34. JWH-149;
717	697		35. JWH-150;
718	698		36. JWH-156;
719	699		37. JWH-167;
720	700		38. JWH-175;
721	701		39. JWH-180;
722	702		40. JWH-181;
723	703		41. JWH-182;
724	704		42. JWH-184;
725	705		43. JWH-185;
726	706		44. JWH-189;
727	707		45. JWH-192;
	708	+	46. JWH-193;
	709	+	47. JWH-194;
	710	+	48. JWH-195;
	711	+	49. JWH-196;
728	712
729		-	SB12 HFLR Page 15
730		-	BOLD FACE denotes Committee Amendments. 1
	713	+	ENGR. S. B. NO. 12 Page 15 1
731	714		2
732	715		3
733	716		4
734	717		5
735	718		6
736	719		7
737	720		8
738	721		9
739	722		10
740	723		11
741	724		12
742	725		13
743	726		14
744	727		15
745	728		16
746	729		17
747	730		18
748	731		19
749	732		20
750	733		21
751	734		22
752	735		23
753	736		24
754	737
755		-	46. JWH-193;
756		-	47. JWH-194;
757		-	48. JWH-195;
758		-	49. JWH-196;
759	738		50. JWH-197;
760	739		51. JWH-198;
761	740		52. JWH-199;
762	741		53. JWH-200;
763	742		54. JWH-201;
764	743		55. JWH-202;
765	744		56. JWH-203;
766	745		57. JWH-204;
767	746		58. JWH-205;
768	747		59. JWH-206;
769	748		60. JWH-207;
770	749		61. JWH-208;
771	750		62. JWH-209;
772	751		63. JWH-210;
773	752		64. JWH-211;
774	753		65. JWH-212;
775	754		66. JWH-213;
776	755		67. JWH-234;
777	756		68. JWH-235;
778	757		69. JWH-236;
	758	+	70. JWH-237;
	759	+	71. JWH-239;
	760	+	72. JWH-240;
	761	+	73. JWH-241;
779	762
780		-	SB12 HFLR Page 16
781		-	BOLD FACE denotes Committee Amendments. 1
	763	+	ENGR. S. B. NO. 12 Page 16 1
782	764		2
783	765		3
784	766		4
785	767		5
786	768		6
787	769		7
788	770		8
789	771		9
790	772		10
791	773		11
792	774		12
793	775		13
794	776		14
795	777		15
796	778		16
797	779		17
798	780		18
799	781		19
800	782		20
801	783		21
802	784		22
803	785		23
804	786		24
805	787
806		-	70. JWH-237;
807		-	71. JWH-239;
808		-	72. JWH-240;
809		-	73. JWH-241;
810	788		74. JWH-242;
811	789		75. JWH-243;
812	790		76. JWH-244;
813	791		77. JWH-245;
814	792		78. JWH-246;
815	793		79. JWH-248;
816	794		80. JWH-249;
817	795		81. JWH-250;
818	796		82. JWH-251;
819	797		83. JWH-252;
820	798		84. JWH-253;
821	799		85. JWH-262;
822	800		86. JWH-292;
823	801		87. JWH-293;
824	802		88. JWH-302;
825	803		89. JWH-303;
826	804		90. JWH-304;
827	805		91. JWH-305;
828	806		92. JWH-306;
829	807		93. JWH-307;
	808	+	94. JWH-308;
	809	+	95. JWH-311;
	810	+	96. JWH-312;
	811	+	97. JWH-313;
830	812
831		-	SB12 HFLR Page 17
832		-	BOLD FACE denotes Committee Amendments. 1
	813	+	ENGR. S. B. NO. 12 Page 17 1
833	814		2
834	815		3
835	816		4
836	817		5
837	818		6
838	819		7
839	820		8
840	821		9
841	822		10
842	823		11
843	824		12
844	825		13
845	826		14
846	827		15
847	828		16
848	829		17
849	830		18
850	831		19
851	832		20
852	833		21
853	834		22
854	835		23
855	836		24
856	837
857		-	94. JWH-308;
858		-	95. JWH-311;
859		-	96. JWH-312;
860		-	97. JWH-313;
861	838		98. JWH-314;
862	839		99. JWH-315;
863	840		100. JWH-316;
864	841		101. JWH-346;
865	842		102. JWH-348;
866	843		103. JWH-363;
867	844		104. JWH-364;
868	845		105. JWH-365;
869	846		106. JWH-367;
870	847		107. JWH-368;
871	848		108. JWH-369;
872	849		109. JWH-370;
873	850		110. JWH-371;
874	851		111. JWH-373;
875	852		112. JWH-386;
876	853		113. JWH-387;
877	854		114. JWH-392;
878	855		115. JWH-394;
879	856		116. JWH-395;
880	857		117. JWH-397;
	858	+	118. JWH-398;
	859	+	119. JWH-399;
	860	+	120. JWH-400;
	861	+	121. JWH-412;
881	862
882		-	SB12 HFLR Page 18
883		-	BOLD FACE denotes Committee Amendments. 1
	863	+	ENGR. S. B. NO. 12 Page 18 1
884	864		2
885	865		3
886	866		4
887	867		5
888	868		6
889	869		7
890	870		8
891	871		9
892	872		10
893	873		11
894	874		12
895	875		13
896	876		14
897	877		15
898	878		16
899	879		17
900	880		18
901	881		19
902	882		20
903	883		21
904	884		22
905	885		23
906	886		24
907	887
908		-	118. JWH-398;
909		-	119. JWH-399;
910		-	120. JWH-400;
911		-	121. JWH-412;
912	888		122. JWH-413;
913	889		123. JWH-414;
914	890		124. JWH-415;
915	891		125. CP-55, 940;
916	892		126. CP-47, 497;
917	893		127. HU-210;
918	894		128. HU-211;
919	895		129. WIN-55, 212-2;
920	896		130. AM-2201;
921	897		131. AM-2233;
922	898		132. JWH-018 adamantyl-carboxamide;
923	899		133. AKB48;
924	900		134. JWH-122 N-(4-pentenyl)analog;
925	901		135. MAM2201;
926	902		136. URB597;
927	903		137. URB602;
928	904		138. URB754;
929	905		139. UR144;
930	906		140. XLR11;
931	907		141. A-796,260;
	908	+	142. STS-135;
	909	+	143. AB-FUBINACA;
	910	+	144. AB-PINACA;
	911	+	145. PB-22;
932	912
933		-	SB12 HFLR Page 19
934		-	BOLD FACE denotes Committee Amendments. 1
	913	+	ENGR. S. B. NO. 12 Page 19 1
935	914		2
936	915		3
937	916		4
938	917		5
939	918		6
940	919		7
941	920		8
942	921		9
943	922		10
944	923		11
945	924		12
946	925		13
947	926		14
948	927		15
949	928		16
950	929		17
951	930		18
952	931		19
953	932		20
954	933		21
955	934		22
956	935		23
957	936		24
958	937
959		-	142. STS-135;
960		-	143. AB-FUBINACA;
961		-	144. AB-PINACA;
962		-	145. PB-22;
963	938		146. AKB48 N-5-Fluorpentyl;
964	939		147. AM1248;
965	940		148. FUB-PB-22;
966	941		149. ADB-FUBINACA;
967	942		150. BB-22;
968	943		151. 5-Fluoro PB-22; or
969	944		152. 5-Fluoro AKB-48.
970	945		G. In addition to those substances listed in subsection F of
971	946		this section, unless specifically excepted or unless listed i n
972	947		another schedule, any material, compou nd, mixture, or preparation
973	948		which contains any quantity of a synthetic cannabinoid found to be
974	949		in any of the following chemical groups:
975	950		1. Naphthoylindoles: a ny compound containing a 3-(1-
976	951		naphthoyl)indole structure with or without substitution at the
977	952		nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl,
978	953		alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1 -
979	954		(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-
980	955		2-pyrrolidinyl)methyl, 1-(N-methyl-3- morpholinyl)methyl,
981	956		(tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or
982	957		halophenyl group, whether or not further substituted on the indole
	958	+	ring to any extent, and whether or not substituted on the naphthyl
	959	+	ring to any extent. N aphthoylindoles include, but are not lim ited
	960	+	to:
983	961
984		-	SB12 HFLR Page 20
985		-	BOLD FACE denotes Committee Amendments. 1
	962	+	ENGR. S. B. NO. 12 Page 20 1
986	963		2
987	964		3
988	965		4
989	966		5
990	967		6
991	968		7
992	969		8
993	970		9
994	971		10
995	972		11
996	973		12
997	974		13
998	975		14
999	976		15
1000	977		16
1001	978		17
1002	979		18
1003	980		19
1004	981		20
1005	982		21
1006	983		22
1007	984		23
1008	985		24
1009	986
1010		-	ring to any extent, and whether or not substituted on the naphthyl
1011		-	ring to any extent. Naphthoylindoles include, but are not limited
1012		-	to:
1013	987		a. 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-
1014	988		200),
1015	989		b. 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201),
1016	990		c. 1-pentyl-3-(1-naphthoyl)indole (JWH-018),
1017	991		d. 1-butyl-3-(1-naphthoyl)indole (JWH -073),
1018	992		e. 1-pentyl-3-(4-methoxy-1-naphthoyl)indole (JWH-081),
1019	993		f. 1-propyl-2-methyl-3-(1-naphthoyl)indole (JWH-015),
1020	994		g. 1-hexyl-3-(1-naphthoyl)indole (JWH -019),
1021	995		h. 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH -122),
1022	996		i. 1-pentyl-3-(4-ethyl-1-naphthoyl)indole (JWH -210),
1023	997		j. 1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398),
1024	998		k. 1-pentyl-2-methyl-3-(1-naphthoyl)indole (JWH-007),
1025	999		l. 1-pentyl-3-(7-methoxy-1-naphthoyl)indole (JWH -164),
1026	1000		m. 1-pentyl-2-methyl-3-(4-methoxy-1-naphthoyl)indole
1027	1001		(JWH-098),
1028	1002		n. 1-pentyl-3-(4-fluoro-1-naphthoyl)indole (JWH-412),
1029	1003		o. 1-[1-(N-methyl-2-piperidinyl)methyl]-3-(1-
1030	1004		naphthoyl)indole (AM-1220),
1031	1005		p. 1-(5-fluoropentyl)-3-(4-methyl-1-naphthoyl)indole
1032	1006		(MAM-2201), or
1033	1007		q. 1-(4-cyanobutyl)-3-(1-naphthoyl)indole (AM -2232);
	1008	+	2. Naphthylmethylindoles: any com pound containing a 1H-indol-3-
	1009	+	yl-(1-naphthyl)methane structure with or without substitution at the
	1010	+	nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl,
1034	1011
1035		-	SB12 HFLR Page 21
1036		-	BOLD FACE denotes Committee Amendments. 1
	1012	+	ENGR. S. B. NO. 12 Page 21 1
1037	1013		2
1038	1014		3
1039	1015		4
1040	1016		5
1041	1017		6
1042	1018		7
1043	1019		8
1044	1020		9
1045	1021		10
1046	1022		11
1047	1023		12
1048	1024		13
1049	1025		14
1050	1026		15
1051	1027		16
1052	1028		17
1053	1029		18
1054	1030		19
1055	1031		20
1056	1032		21
1057	1033		22
1058	1034		23
1059	1035		24
1060	1036
1061		-	2. Naphthylmethylindoles: any compound containing a 1H -indol-3-
1062		-	yl-(1-naphthyl)methane structure with or without substitution at the
1063		-	nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl,
1064	1037		alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl , halobenzyl, 1-
1065	1038		(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1 -(N-methyl-
1066	1039		2-pyrrolidinyl)methyl, 1-(N-methyl-3- morpholinyl)methyl,
1067	1040		(tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl , or
1068	1041		halophenyl group, whether or not further substituted on the indole
1069	1042		ring to any extent, and wh ether or not substituted on the naphthyl
1070	1043		ring to any extent. Naphthylmethylindoles include, but are not
1071	1044		limited to, (1-pentylindol-3-yl)(1-naphthyl)methane (JWH -175);
1072	1045		3. Naphthoylpyrroles: any compound containing a 3 -(1-
1073	1046		naphthoyl)pyrrole structure with o r without substitution at the
1074	1047		nitrogen atom of the pyrrole ring by an alkyl, haloalkyl,
1075	1048		cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl,
1076	1049		halobenzyl, 1-(N-methyl-2-piperidinyl)methyl, 2 -(4-
1077	1050		morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
1078	1051		morpholinyl)methyl, (tetr ahydropyran-4-yl)methyl, 1-methylazepanyl,
1079	1052		phenyl, or halophenyl group, whether or not further substituted on
1080	1053		the pyrrole ring to any extent, and whether or not substituted on
1081	1054		the naphthyl group to any extent. Napht hoylpyrroles include, but
1082	1055		are not limited to:
1083	1056		a. 1-hexyl-2-phenyl-4-(1-naphthoyl)pyrrole (JWH-147),
	1057	+	b. 1-pentyl-5-(2-methylphenyl)-3-(1-naphthoyl)pyrrole
	1058	+	(JWH-370),
	1059	+	c. 1-pentyl-3-(1-naphthoyl)pyrrole (JWH -030), or
	1060	+	d. 1-hexyl-5-phenyl-3-(1-naphthoyl)pyrrole (JWH-147);
1084	1061
1085		-	SB12 HFLR Page 22
1086		-	BOLD FACE denotes Committee Amendments. 1
	1062	+	ENGR. S. B. NO. 12 Page 22 1
1087	1063		2
1088	1064		3
1089	1065		4
1090	1066		5
1091	1067		6
1092	1068		7
1093	1069		8
1094	1070		9
1095	1071		10
1096	1072		11
1097	1073		12
1098	1074		13
1099	1075		14
1100	1076		15
1101	1077		16
1102	1078		17
1103	1079		18
1104	1080		19
1105	1081		20
1106	1082		21
1107	1083		22
1108	1084		23
1109	1085		24
1110	1086
1111		-	b. 1-pentyl-5-(2-methylphenyl)-3-(1-naphthoyl)pyrrole
1112		-	(JWH-370),
1113		-	c. 1-pentyl-3-(1-naphthoyl)pyrrole (JWH -030), or
1114		-	d. 1-hexyl-5-phenyl-3-(1-naphthoyl)pyrrole (JWH -147);
1115	1087		4. Naphthylideneindenes: an y compound containing a 1-(1-
1116	1088		naphthylmethylene)indene structure with or without substitution at
1117	1089		the 3-position of the indene ring by an alkyl, haloalkyl,
1118	1090		cyanoalkyl, alkenyl, cyc loalkylmethyl, cycloalkylethyl, benzyl ,
1119	1091		halobenzyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-
1120	1092		morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1 -(N-methyl-3-
1121	1093		morpholinyl)methyl, (tetrahydropyran -4-yl)methyl, 1-methylazepanyl,
1122	1094		phenyl, or halophenyl group, whether or not further substituted on
1123	1095		the indene group to any extent, and whet her or not substituted on
1124	1096		the naphthyl group to any extent. Naphthylmethylindenes include,
1125	1097		but are not limited to, (1 -[(3-pentyl)-1H-inden-1-
1126	1098		ylidene)methyl]naphthalene (JWH -176);
1127	1099		5. Phenylacetylindoles: any compoun d containing a 3-
1128	1100		phenylacetylindole stru cture with or without substitution at the
1129	1101		nitrogen atom of the indole ring by alkyl, haloalkyl, cyanoalkyl,
1130	1102		alkenyl, cycloalkylme thyl, cycloalkylethyl, benzyl, halobenzyl, 1 -
1131	1103		(N-methyl-2-piperidinyl)methyl, 2 -(4-morpholinyl)ethyl, 1-(N-methyl-
1132	1104		2-pyrrolidinyl)methyl, 1-(N-methyl-3- morpholinyl)methyl,
1133	1105		(tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl , or
1134	1106		halophenyl group, whether or not further substituted on the indole
	1107	+	ring to any extent, and whether or not substit uted on the phenyl
	1108	+	ring to any extent. Phenylacetylindoles include, but are not
	1109	+	limited to:
	1110	+	a. 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH -250),
1135	1111
1136		-	SB12 HFLR Page 23
1137		-	BOLD FACE denotes Committee Amendments. 1
	1112	+	ENGR. S. B. NO. 12 Page 23 1
1138	1113		2
1139	1114		3
1140	1115		4
1141	1116		5
1142	1117		6
1143	1118		7
1144	1119		8
1145	1120		9
1146	1121		10
1147	1122		11
1148	1123		12
1149	1124		13
1150	1125		14
1151	1126		15
1152	1127		16
1153	1128		17
1154	1129		18
1155	1130		19
1156	1131		20
1157	1132		21
1158	1133		22
1159	1134		23
1160	1135		24
1161	1136
1162		-	ring to any extent, and wheth er or not substituted on the phenyl
1163		-	ring to any extent. Phenylacetylindoles include, but are not
1164		-	limited to:
1165		-	a. 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH -250),
1166	1137		b. 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole
1167	1138		(RCS-8),
1168	1139		c. 1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203),
1169	1140		d. 1-pentyl-3-(2-methylphenylacetyl)indole (JWH-251),
1170	1141		e. 1-pentyl-3-(4-methoxyphenylacetyl)indole (JWH -201), or
1171	1142		f. 1-pentyl-3-(3-methoxyphenylacetyl)indole ( JWH-302);
1172	1143		6. Cyclohexylphenols: any compound con taining a 2-(3-
1173	1144		hydroxycyclohexyl)pheno l structure with or without substitution at
1174	1145		the 5-position of the phenolic ring by an alkyl, haloalkyl,
1175	1146		cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl,
1176	1147		halobenzyl, 1-(N-methyl-2-piperidinyl)methyl, 2 -(4-
1177	1148		morpholinyl)ethyl, 1 -(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
1178	1149		morpholinyl)methyl, (tetrahydropyran-4-yl)methyl, 1-methylazepanyl,
1179	1150		phenyl, or halophenyl group, and whether or not further substituted
1180	1151		on the cyclohexyl ring to any extent. Cyclohexylp henols include,
1181	1152		but are not limited to :
1182	1153		a. 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-
1183	1154		hydroxycyclohexyl]-phenol (CP-47,497),
	1155	+	b. 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-
	1156	+	phenol (cannabicyclohexanol; CP -47,497 C8 homologue),
	1157	+	or
	1158	+	c. 5-(1,1-dimethylheptyl)-2-[(1R,2R)-5-hydroxy-2-(3-
	1159	+	hydroxypropyl)cyclohexyl]-phenol (CP 55, 940);
1184	1160
1185		-	SB12 HFLR Page 24
1186		-	BOLD FACE denotes Committee Amendments. 1
	1161	+	ENGR. S. B. NO. 12 Page 24 1
1187	1162		2
1188	1163		3
1189	1164		4
1190	1165		5
1191	1166		6
1192	1167		7
1193	1168		8
1194	1169		9
1195	1170		10
1196	1171		11
1197	1172		12
1198	1173		13
1199	1174		14
1200	1175		15
1201	1176		16
1202	1177		17
1203	1178		18
1204	1179		19
1205	1180		20
1206	1181		21
1207	1182		22
1208	1183		23
1209	1184		24
1210	1185
1211		-	b. 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-
1212		-	phenol (cannabicyclohexanol; CP -47,497 C8 homologue),
1213		-	or
1214		-	c. 5-(1,1-dimethylheptyl)-2-[(1R,2R)-5-hydroxy-2-(3-
1215		-	hydroxypropyl)cyclohexyl] -phenol (CP 55, 940);
1216	1186		7. Benzoylindoles: any compound containing a 3-(benzoyl)indole
1217	1187		structure with or without substitution at the nitrogen atom of the
1218	1188		indole ring by an alkyl, haloalkyl, cyanoalkyl, al kenyl,
1219	1189		cycloalkylmethyl, cycloalkyleth yl, benzyl, halobenzyl, 1-(N-methyl-
1220	1190		2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-
1221	1191		pyrrolidinyl)methyl, 1 -(N-methyl-3- morpholinyl)methyl,
1222	1192		(tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl , or
1223	1193		halophenyl group, whether or not further subs tituted on the indole
1224	1194		ring to any extent, and whether or not substituted on the phenyl
1225	1195		group to any extent. Benzoylindoles include, but are not limited
1226	1196		to:
1227	1197		a. 1-pentyl-3-(4-methoxybenzoyl)indole (RCS -4),
1228	1198		b. 1-[2-(4-morpholinyl)ethyl]-2-methyl-3-(4-
1229	1199		methoxybenzoyl)indole (Pravadoline or WIN 48, 0 98),
1230	1200		c. 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM-694),
1231	1201		d. 1-pentyl-3-(2-iodobenzoyl)indole (AM -679), or
1232	1202		e. 1-[1-(N-methyl-2-piperidinyl)methyl]-3-(2-
1233	1203		iodobenzoyl)indole (AM -2233);
	1204	+	8. Cyclopropoylindoles: Any co mpound containing a 3-
	1205	+	(cyclopropoyl)indole structure with substitution at the nitrogen
	1206	+	atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl,
	1207	+	cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1 -(N-methyl-
	1208	+	2-piperidinyl)methyl, 2 -(4-morpholinyl)ethyl, 1-(N-methyl-2-
	1209	+	pyrrolidinyl)methyl, 1-(N-methyl-3- morpholinyl)methyl,
1234	1210
1235		-	SB12 HFLR Page 25
1236		-	BOLD FACE denotes Committee Amendments. 1
	1211	+	ENGR. S. B. NO. 12 Page 25 1
1237	1212		2
1238	1213		3
1239	1214		4
1240	1215		5
1241	1216		6
1242	1217		7
1243	1218		8
1244	1219		9
1245	1220		10
1246	1221		11
1247	1222		12
1248	1223		13
1249	1224		14
1250	1225		15
1251	1226		16
1252	1227		17
1253	1228		18
1254	1229		19
1255	1230		20
1256	1231		21
1257	1232		22
1258	1233		23
1259	1234		24
1260	1235
1261		-	8. Cyclopropoylindoles: Any compound containing a 3 -
1262		-	(cyclopropoyl)indole structure with substitution at the nitrogen
1263		-	atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl,
1264		-	cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1 -(N-methyl-
1265		-	2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1 -(N-methyl-2-
1266		-	pyrrolidinyl)methyl, 1 -(N-methyl-3- morpholinyl)methyl,
1267	1236		(tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl , or
1268	1237		halophenyl group, whether or not further substituted in the indole
1269	1238		ring to any extent and whether or not substitut ed in the
1270	1239		cyclopropoyl ring to any exten t. Cyclopropoylindoles include, but
1271	1240		are not limited to:
1272	1241		a. 1-pentyl-3-(2,2,3,3-tetramethylcyclopropoyl)indole
1273	1242		(UR-144),
1274	1243		b. 1-(5-chloropentyl)-3-(2,2,3,3-
1275	1244		tetramethylcyclopropoyl) indole (5Cl-UR-144), or
1276	1245		c. 1-(5-fluoropentyl)-3-(2,2,3,3-
1277	1246		tetramethylcyclopropo yl)indole (XLR11);
1278	1247		9. Indole Amides: Any compound containing a 1H-Indole-3-
1279	1248		carboxamide structure with or without substitution at the nitrogen
1280	1249		atom of the indole ring by an alky l, haloalkyl, cyanoalkyl, alkenyl,
1281	1250		cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-(N-methyl-
1282	1251		2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1 -(N-methyl-2-
1283	1252		pyrrolidinyl)methyl, 1 -(N-methyl-3- morpholinyl)methyl,
1284	1253		(tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or
	1254	+	halophenyl group, whether or not substituted at the carbo xamide
	1255	+	group by an adamantyl, naphthyl, phenyl, benzyl, quinolinyl,
	1256	+	cycloalkyl, 1-amino-3-methyl-1-oxobutan-2-yl, 1-amino-3,3-dimethyl-
	1257	+	1-oxobutan-2-yl, 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-methoxy-3,3-
	1258	+	dimethyl-1-oxobutan-2-yl or pyrrole group, and whether or not
	1259	+	further substituted in the indole, adamantyl, naphthyl, phenyl,
1285	1260
1286		-	SB12 HFLR Page 26
1287		-	BOLD FACE denotes Committee Amendments. 1
	1261	+	ENGR. S. B. NO. 12 Page 26 1
1288	1262		2
1289	1263		3
1290	1264		4
1291	1265		5
1292	1266		6
1293	1267		7
1294	1268		8
1295	1269		9
1296	1270		10
1297	1271		11
1298	1272		12
1299	1273		13
1300	1274		14
1301	1275		15
1302	1276		16
1303	1277		17
1304	1278		18
1305	1279		19
1306	1280		20
1307	1281		21
1308	1282		22
1309	1283		23
1310	1284		24
1311	1285
1312		-	halophenyl group, whether or not substituted at the carboxamide
1313		-	group by an adamantyl, naphthyl, phenyl, benzyl, quinolinyl,
1314		-	cycloalkyl, 1-amino-3-methyl-1-oxobutan-2-yl, 1-amino-3,3-dimethyl-
1315		-	1-oxobutan-2-yl, 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-methoxy-3,3-
1316		-	dimethyl-1-oxobutan-2-yl or pyrrole group, and whether or not
1317		-	further substituted in the indole, adamantyl, naphthyl, phenyl,
1318	1286		pyrrole, quninolinyl , or cycloalkyl rings to any extent. Indole
1319	1287		Amides include, but are not limited to:
1320	1288		a. N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide
1321	1289		(2NE1),
1322	1290		b. N-(1-adamantyl)-1-(5-fluoropentyl-1H-indole-3-
1323	1291		carboxamide (STS-135),
1324	1292		c. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-
1325	1293		indole-3-carboxamide (ADBICA),
1326	1294		d. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-
1327	1295		fluoropentyl)-1H-indole-3-carboxamide (5F-ADBICA),
1328	1296		e. N-(naphthalen-1-yl)-1-pentyl-1H-indole-3-carboxamide
1329	1297		(NNE1),
1330	1298		f. 1-(5-fluoropentyl)-N-(naphthalene-1-yl)-1H-indole-3-
1331	1299		carboxamide (5F-NNE1),
1332	1300		g. N-benzyl-1-pentyl-1H-indole-3-carboxamide (SDB-006),
1333	1301		or
1334	1302		h. N-benzyl-1-(5-fluoropentyl)-1H-indole-3-carboxamide
1335	1303		(5F-SDB-006);
	1304	+	10. Indole Esters: Any compound containing a 1H-Indole-3-
	1305	+	carboxylate structure with or without substitution at the nitrogen
	1306	+	atom of the indole ring by an alkyl, haloalkyl, cyanoa lkyl, alkenyl,
	1307	+	cycloalkylmethyl, cyclo alkylethyl, benzyl, halobenzyl, 1 -(N-methyl-
	1308	+	2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-
	1309	+	pyrrolidinyl)methyl, 1 -(N-methyl-3-morpholinyl)methyl,
1336	1310
1337		-	SB12 HFLR Page 27
1338		-	BOLD FACE denotes Committee Amendments. 1
	1311	+	ENGR. S. B. NO. 12 Page 27 1
1339	1312		2
1340	1313		3
1341	1314		4
1342	1315		5
1343	1316		6
1344	1317		7
1345	1318		8
1346	1319		9
1347	1320		10
1348	1321		11
1349	1322		12
1350	1323		13
1351	1324		14
1352	1325		15
1353	1326		16
1354	1327		17
1355	1328		18
1356	1329		19
1357	1330		20
1358	1331		21
1359	1332		22
1360	1333		23
1361	1334		24
1362	1335
1363		-	10. Indole Esters: Any compound containing a 1H -Indole-3-
1364		-	carboxylate structure with or without substitution at the nitrogen
1365		-	atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl,
1366		-	cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1 -(N-methyl-
1367		-	2-piperidinyl)methyl, 2 -(4-morpholinyl)ethyl, 1 -(N-methyl-2-
1368		-	pyrrolidinyl)methyl, 1 -(N-methyl-3-morpholinyl)methyl,
1369	1336		(tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl , or
1370	1337		halophenyl group, whether or not subst ituted at the carboxylate
1371	1338		group by an adamantyl, naphthyl, phenyl, benzyl, quinolinyl,
1372	1339		cycloalkyl,1-amino-3-methyl-1-oxobutan-2-yl, 1-amino-3,3-dimethyl-1-
1373	1340		oxobutan-2-yl, 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-methoxy-3,3-
1374	1341		dimethyl-1-oxobutan-2-yl or pyrrole group, and whether or not
1375	1342		further substituted in the indole, adamantyl, naphthyl, phenyl,
1376	1343		pyrrole, quinolinyl, or cycloalkyl rings to any extent. Indole
1377	1344		Esters include, but are not limited to:
1378	1345		a. quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (PB-
1379	1346		22),
1380	1347		b. quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-
1381	1348		carboxylate (5F-PB-22),
1382	1349		c. quinolin-8-yl 1-(cyclohexylmethyl)-1H-indole-3-
1383	1350		carboxylate (BB-22),
1384	1351		d. naphthalen-1-yl 1-(4-fluorobenzyl)-1H-indole-3-
1385	1352		carboxylate (FDU-PB-22), or
	1353	+	e. naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-
	1354	+	carboxylate (NM2201);
	1355	+	11. Adamantanoylindoles: Any compound containing an
	1356	+	adamantanyl-(1H-indol-3-yl)methanone structure with or without
	1357	+	substitution at the nitrogen atom of the indole ring by an alkyl,
	1358	+	haloalkyl, cyanoalkyl, alkenyl, cycloal kylmethyl, cycloalkylethyl,
	1359	+	benzyl, halobenzyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-
1386	1360
1387		-	SB12 HFLR Page 28
1388		-	BOLD FACE denotes Committee Amendments. 1
	1361	+	ENGR. S. B. NO. 12 Page 28 1
1389	1362		2
1390	1363		3
1391	1364		4
1392	1365		5
1393	1366		6
1394	1367		7
1395	1368		8
1396	1369		9
1397	1370		10
1398	1371		11
1399	1372		12
1400	1373		13
1401	1374		14
1402	1375		15
1403	1376		16
1404	1377		17
1405	1378		18
1406	1379		19
1407	1380		20
1408	1381		21
1409	1382		22
1410	1383		23
1411	1384		24
1412	1385
1413		-	e. naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-
1414		-	carboxylate (NM2201);
1415		-	11. Adamantanoylindoles: Any compound containing an
1416		-	adamantanyl-(1H-indol-3-yl)methanone structure with or without
1417		-	substitution at the nitrogen atom of the indole ring by an alkyl,
1418		-	haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
1419		-	benzyl, halobenzyl, 1 -(N-methyl-2-piperidinyl)methyl, 2 -(4-
1420	1386		morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1 -(N-methyl-3-
1421	1387		morpholinyl)methyl, (tetrahydropyran -4-yl)methyl, 1-methylazepanyl,
1422	1388		phenyl, or halophenyl group, whe ther or not further substituted in
1423	1389		the indole ring to any extent and whether or not substituted in the
1424	1390		adamantyl ring to any extent. Adamantanoylindoles include, but are
1425	1391		not limited to:
1426	1392		a. adamantan-1-yl[1-[(1-methyl-2-piperidinyl)methyl]-1H-
1427	1393		indol-3-yl]methanone (AM1248), or
1428	1394		b. adamantan-1-yl-(1-pentyl-1H-indol-3-yl)methanone (AB-
1429	1395		001);
1430	1396		12. Carbazole Ketone: Any compound containing (9H -carbazole-3-
1431	1397		yl) methanone structure with or without substitution at the nitrogen
1432	1398		atom of the carbazole ring by an alkyl, haloalkyl, cyanoalkyl,
1433	1399		alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-
1434	1400		(N-methyl-2-piperidinyl)methyl, 2 -(4-morpholinyl)ethyl, 1 -(N-methyl-
1435	1401		2-pyrrolidinyl)methyl, 1 -(N-methyl-3-morpholinyl)methyl,
1436	1402		(tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or
	1403	+	halophenyl group, with substitution at the carbon of the methanone
	1404	+	group by an adamantyl, naphthyl, phenyl, benzyl, quinolinyl,
	1405	+	cycloalkyl, 1-amino-3-methyl-1-oxobutan-2-yl, 1-amino-3,3-dimethyl-
	1406	+	1-oxobutan-2-yl, 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-methoxy-3,3-
	1407	+	dimethyl-1-oxobutan-2-yl or pyrrole group, and whether or not
	1408	+	further substituted at the carbazole, adamantyl, naphthyl, phenyl,
	1409	+	pyrrole, quinolinyl, or cycloalkyl rings to any extent. Carbazole
1437	1410
1438		-	SB12 HFLR Page 29
1439		-	BOLD FACE denotes Committee Amendments. 1
	1411	+	ENGR. S. B. NO. 12 Page 29 1
1440	1412		2
1441	1413		3
1442	1414		4
1443	1415		5
1444	1416		6
1445	1417		7
1446	1418		8
1447	1419		9
1448	1420		10
1449	1421		11
1450	1422		12
1451	1423		13
1452	1424		14
1453	1425		15
1454	1426		16
1455	1427		17
1456	1428		18
1457	1429		19
1458	1430		20
1459	1431		21
1460	1432		22
1461	1433		23
1462	1434		24
1463	1435
1464		-	halophenyl group, with substitution at the carbon of the methanone
1465		-	group by an adamantyl, naphthyl, phenyl, benzyl, quinolinyl,
1466		-	cycloalkyl, 1-amino-3-methyl-1-oxobutan-2-yl, 1-amino-3,3-dimethyl-
1467		-	1-oxobutan-2-yl, 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-methoxy-3,3-
1468		-	dimethyl-1-oxobutan-2-yl or pyrrole group, and whether or not
1469		-	further substituted at the carbazole, adamantyl, naphthyl, phenyl,
1470		-	pyrrole, quinolinyl, or cycloalkyl rings to any extent. Carbazole
1471	1436		Ketones include, but are not limited to, naphthalen-1-yl(9-pentyl-
1472	1437		9H-carbazol-3-yl)methanone (EG-018);
1473	1438		13. Benzimidazole Ketone: Any compound containing
1474	1439		(benzimidazole-2-yl) methanone structure with or without
1475	1440		substitution at either nitrogen atom of the benzimidazole ring by an
1476	1441		alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmet hyl,
1477	1442		cycloalkylethyl, benzyl, halobenzyl, 1-(N-methyl-2-
1478	1443		piperidinyl)methyl, 2 -(4-morpholinyl)ethyl, 1 -(N-methyl-2-
1479	1444		pyrrolidinyl)methyl, 1 -(N-methyl-3-morpholinyl)methyl,
1480	1445		(tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or
1481	1446		halophenyl group, with subst itution at the carbon of the methanone
1482	1447		group by an adamantyl, naphthyl, phenyl, benzyl, quinolinyl,
1483	1448		cycloalkyl, 1-amino-3-methyl-1-oxobutan-2-yl, 1-amino-3,3-dimethyl-
1484	1449		1-oxobutan-2-yl, 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-methoxy-3,3-
1485	1450		dimethyl-1-oxobutan-2-yl or pyrrole group, and whether or not
1486	1451		further substituted in the benzimidazole, adamantyl, naphthyl,
	1452	+	phenyl, pyrrole, quinolinyl , or cycloalkyl rings to any extent.
	1453	+	Benzimidazole Ketones include, but are not limit ed to:
	1454	+	a. naphthalen-1-yl(1-pentyl-1H-benzo[d]imidazol-2-
	1455	+	l)methanone (JWH-018 benzimidazole analog), or
	1456	+	b. (1-(5-fluoropentyl)-1H-benzo[d]imidazol-2-
	1457	+	yl)(naphthalen-1-yl)methanone (FUBIMINA); and
1487	1458
1488		-	SB12 HFLR Page 30
1489		-	BOLD FACE denotes Committee Amendments. 1
	1459	+	ENGR. S. B. NO. 12 Page 30 1
1490	1460		2
1491	1461		3
1492	1462		4
1493	1463		5
1494	1464		6
1495	1465		7
1496	1466		8
1497	1467		9
1498	1468		10
1499	1469		11
1500	1470		12
1501	1471		13
1502	1472		14
1503	1473		15
1504	1474		16
1505	1475		17
1506	1476		18
1507	1477		19
1508	1478		20
1509	1479		21
1510	1480		22
1511	1481		23
1512	1482		24
1513	1483
1514		-	phenyl, pyrrole, quinolinyl , or cycloalkyl rings to any extent.
1515		-	Benzimidazole Ketones include, but are not limited to:
1516		-	a. naphthalen-1-yl(1-pentyl-1H-benzo[d]imidazol-2-
1517		-	l)methanone (JWH-018 benzimidazole analog), or
1518		-	b. (1-(5-fluoropentyl)-1H-benzo[d]imidazol-2-
1519		-	yl)(naphthalen-1-yl)methanone (FUBIMINA); and
1520	1484		14. Modified by Replac ement: any compound defined in this
1521	1485		subsection that is modified by replacemen t of a carbon with nitrogen
1522	1486		in the indole, naphthyl, indene, benzimidazole , or carbazole ring.
1523	1487		SECTION 2. This act shall become effective November 1, 202 1.
	1488	+	Passed the Senate the 11th day of February, 2021.
1524	1489
1525		-	COMMITTEE REPORT BY: COMM ITTEE ON ALCOHOL, TOBACCO AND CONTROLLED
1526		-	SUBSTANCES, dated 04/08/2021 - DO PASS.
	1490	+
	1491	+
	1492	+	Presiding Officer of the Senate
	1493	+
	1494	+
	1495	+	Passed the House of Repre sentatives the ____ day of __________,
	1496	+	2021.
	1497	+
	1498	+
	1499	+
	1500	+	Presiding Officer of the House
	1501	+	of Representatives
	1502	+